The technology called Tissue Nanotransfection (TNT) is still in its experimental phase but it holds promise in saving the lives of vehicle crash victims and deployed soldiers who get injured on site.
A small electric current fires DNA into skin cells to convert them into natural cell building blocks which helps to fix the damaged areas such as arteries and even organs like the heart.
To work, a doctor merely needs to place the chip on a person's wound and the device sends an electrical pulse that converts living cells into whatever cells the body needs them to be.
"By using our novel nanochip technology, injured or compromised organs can be replaced", Sen said in a press release.
Researchers were able to reprogram skin cells to become vascular cells in severely injured legs that lacked blood flow. The pulse opens a small window into the cell that allows the chip to send in a new genetic code - and the whole process takes less than a second.
Ohio State University developed a new device that researchers say can start healing organs in a fraction of a second. One week after the application of TNT, vascular vessels reappeared. The findings are published in the journal Nature Nanotechnology.
The breakthrough technology marks the first time that cells have been reprogrammed in a live body.
Thus far, researchers say that the technique has worked 98 percent of the time.
It's a new take on gene therapy - the act of inserting carefully selected DNA into the body to treat a disease - in this instance, TNT's charge-based strategy delivers DNA straight into cells. Additionally, this technology does away with the need to use viruses as a delivery system for the new cells.
Dr Sen co-led the study with L. James Lee, professor of chemical and biomolecular engineering, Ohio State's College of Engineering in collaboration with Ohio State's Nanoscale Science and Engineering Center. In my lab, we have ongoing research trying to understand the mechanism and do even better.
In a second experiment, skin cells were converted into nerve cells and introduced into the brains of mice crippled by stroke.
Scientists said the procedure is non-invasive and does not require a laboratory, meaning it could be used in hospitals and GP surgeries.
The device is now awaiting FDA approval, but Sen expects that TNT will be tested on humans within this year.